ask="100.00"
ask_size="500"
average_daily_volume="258076"
bid="20.15"
bid_size="100"
book_value="3.79"
change="-0.23"
change_from_200_day_moving_average="2.84"
change_from_50_day_moving_average="0.24"
change_from_52_week_high="-4.15"
change_From_52_week_low="13.53"
change_in_percent="-0.82%"
close="27.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.07"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-3.03"
ex_dividend_date="N/A"
float_shares="15631000"
high="28.12"
high_52_weeks="31.80"
last_trade_date="2/21/2017"
last_trade_price="27.65"
last_trade_size="1333"
last_trade_time="4:00pm"
low="26.74"
low_52_weeks="14.12"
market_capitalization="592.59M"
moving_average_200_day="24.81"
moving_average_50_day="27.41"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="38.17"
open="28.04"
pe_ratio="N/A"
peg_ratio="-0.19"
percent_change_from_200_day_moving_average="+11.45%"
percent_change_from_50_day_moving_average="+0.86%"
percent_change_from_52_week_high="-13.05%"
percent_change_from_52_week_low="+95.82%"
previous_close="27.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.36"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="6.47"
stock_exchange="NMS"
symbol="ACRS"
volume="142163"
weeks_range_52="14.12 - 31.80"
